Active ingredientEpristerideCat. No. P-E072-001CAS 119169-78-7Family · Pharmaceutical analytical standards
Epristeride
A steroidal inhibitor of type II 5-alpha reductase, the enzyme that converts testosterone into the more potent dihydrotestosterone. Developed in the 1990s, it is used for benign prostatic hyperplasia. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It took an unusual path: studied up to phase III in the United States, the United Kingdom and Japan, also for acne and hair loss, it reached the market instead in China, in 2000.
Go to the active ingredient →Active ingredientEpristerideCat. No. P-E072-001CAS 119169-78-7
Isotopically labelledEpristeride-d9Cat. No. P-E072-002
ImpurityEpristeride Impurity 1Cat. No. P-E072-003
ImpurityEpristeride Impurity 2Cat. No. P-E072-005
ImpurityEpristeride Impurity 3Cat. No. P-E072-006
ImpurityEpristeride Impurity 4Cat. No. P-E072-007
ImpurityEpristeride Impurity 5Cat. No. P-E072-008
ImpurityEpristeride Impurity 6Cat. No. P-E072-009
ImpurityEpristeride Impurity 7Cat. No. P-E072-010
ImpurityEpristeride Impurity 8Cat. No. P-E072-011
ImpurityEpristeride Impurity 9Cat. No. P-E072-012No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.